1-5 of 5
midostaurin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clonal evolution and heterogeneity in advanced systemic mastocytosis revealed by single-cell DNA sequencing

Ken-Hong Lim, Jo-Ning Wu, To-Yu Huang, Jie-Yang Jhuang, Yu-Cheng Chang, Huan-Chau Lin, Yi-Hao Chiang, Ying-Wen Su, Caleb Gon-Shen Chen, Yi-Fang Chang, Johnson Lin
Journal: Blood Advances
Blood Adv (2021) 5 (6): 1733–1736.
https://doi.org/10.1182/bloodadvances.2020003980
Published: 2021
Includes: Supplemental data
Journal Articles

Combined inhibition of receptor tyrosine and p21-activated kinases as a therapeutic strategy in childhood ALL

Clinical Trials & Observations
Ina-Katrin Siekmann, Kevin Dierck, Sebastian Prall, Marianne Klokow, Julia Strauss, Sophia Buhs, Antonina Wrzeszcz, Michael Bockmayr, Florian Beck, Magdalena Trochimiuk, Kristina Gottschling, Victoria Martens, Melissa Khosh-Naucke, Helwe Gerull, Jürgen Müller, Lena Behrmann, Martin Blohm, René P. Zahedi, Irmela Jeremias, Albert Sickmann, Peter Nollau, Martin A. Horstmann
Journal: Blood Advances
Blood Adv (2018) 2 (19): 2554–2567.
https://doi.org/10.1182/bloodadvances.2018020693
Published: 2018
Includes: Supplemental data
Journal Articles

Stone RM, Manley PW, Larson RA, Capdeville R. Midostaurin: its odyssey from discovery to approval for treating acute myeloid leukemia and advanced systemic mastocytosis. Blood Adv . 2018;2(4):444-453.

Journal: Blood Advances
Blood Adv (2018) 2 (7): 787.
https://doi.org/10.1182/bloodadvances.2018018481
Published: 2018
Journal Articles

Midostaurin: its odyssey from discovery to approval for treating acute myeloid leukemia and advanced systemic mastocytosis

Clinical Trials & Observations
Richard M. Stone, Paul W. Manley, Richard A. Larson, Renaud Capdeville
Journal: Blood Advances
Blood Adv (2018) 2 (4): 444–453.
https://doi.org/10.1182/bloodadvances.2017011080
Published: 2018
Journal Articles

The role of targeted therapy in the management of patients with AML

Clinical Trials & Observations
Alexander E. Perl
Journal: Blood Advances
Blood Adv (2017) 1 (24): 2281–2294.
https://doi.org/10.1182/bloodadvances.2017009829
Published: 2017